About us
At Kedrion Biopharma, our mission is to enhance lives through our work in the field of rare and ultra-rare diseases.
With a global community of 5,200 people, we are committed to collecting plasma and producing plasma-derived therapies that treat and prevent rare and debilitating conditions such as Coagulation and Neurological Disorders, Immunodeficiencies, and Rh sensitization.
About us
Our extensive network includes 68 plasma collection centers operated by KEDPLASMA in the United States, 8 centers managed by UNICAplasma in the Czech Republic, and 7 production facilities across 5 countries. This infrastructure enables us to distribute 38 life-enhancing and life-saving products in over 100 countries, positioning us as the fifth largest player in the plasma-derived sector worldwide.
With our dedication to developing solutions that address unmet medical needs in rare and ultra-rare diseases, we envision a world where the union of science and care knows no bounds.
In partnership with the medical and scientific community, institutions, patient advocacy groups, and research organizations, we drive sustainable innovation and improve patient care.
What sets us apart from other biopharma companies is our commitment to every detail, every person, every interaction. Whether engaging with donors, supporting patients, empowering our employees, every connection we make impacts someone, somewhere. We call these “rare connections”.
The Power of Rare Connections
No matter how you do it, when you save a life, the world is changed forever. Creating a chain of hope and compassion that transcends an individual action, this sense of human nature drives one person to give the gift of life to many.
At Kedrion, we believe the beauty and responsibility of what we do lies in these connections. That’s why we foster meaningful relationships that others often overlook.
Our strategy prioritizes every detail, every person, every interaction. And this dedication not only changes patients’ lives, but drives our business forward; crfting plasma-derived therapies, treating rare diseases, and developing innovative solutions to treat the humans of tomorrow, we’re committed to digging deeper so we can go where no one else has gone.
Embracing the details of every connection. We create a world where the union of science and care knows no bounds. From donors to patients, doctors to specialized pharmacists, even molecules to cells, We believe in the power of rare connections to impact millions of lives.
Our expertise
In 2024 our Gödöllő plant proudly celebrated its 100th anniversary. For a century, it has stood as a pillar of innovation and patient care in Hungary.
Our expertise
Operating in Hungary through our Human BioPlazma Kft subsidiary, we have carried on the legacy of HUMAN, founded in 1924 to develop sera and vaccines for human use.
The Gödöllő production facility, located just 30 kilometers from Budapest, plays a key role within our global industrial network.
With a plasma fractionation capacity of 600,000 liters. The plant specializes in the production of intermediates for Immunoglobulins and Human Albumin.
Over the years, we have built strong relationships with the local community, distinguishing ourselves for our commitment to the region.
Careers
We are always looking for bright and enthusiastic colleagues to join our team.
Your talent can make a difference and have a significant impact on people’s lives.
We offer opportunities for individuals just starting a career as well as for experienced professionals and managers seeking new challenges.
Careers
Contact us
Thank you for your interest in Kedrion!
Please select the link below that best suits your interest or inquiry.